Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Zafar Khan

Zafar Khan

Professor
Drexel University College of Medicine
USA

Biography

Zafar K. Khan is presently working as a Professor in the Department of Microbiology and Immunology at Drexel University College of Medicine in the United States. Earlier he served as Senior Scientist, Department Chair and Deputy Director Central Drug Research Institute (CDRI) - a premier government organization chartered for novel drugs, diagnostics and human vaccines in India. He has been recipient of numerous fellowships and was Visiting Scientist in Pasteur Institute, France; Forschungs Institute, Germany; Uniformed Services, Bethesda, Maryland; and Texas Tech. Hlth Sci.Center, USA. Dr. Khan has over 30 year’s research experience on microbial pathogenesis and therapy of infectious diseases including retroviruses and opportunistic infections. His current research efforts primarily focus on defining the mechanism of virus-induced neuroinflammation and demyelination in the central and peripheral nervous system in order to identify potential diagnostic markers and targets for therapeutic intervention. His other areas of research are HIV and HCV co-infection, HIV-1 therapeutics & microbicide development, high-throughput (HTS) screening assays, pre-clinical evaluation of antibiotic and antiviral agents, transgenic animal modeling of microbial/viral infections and immunology of neuro-inflammation. Dr. Khan is also an Adjunct Professor, in the Blumberg Institute of Living Sciences, Pennsylvania Biotechnology Center, USA. Dr. Khan has the credited for publishing over 120 research papers, several patents, edited book and book chapters; and is a professional member of numerous prestigious scientific societies.

Research Interest

High throughput screening and preclinical evaluation of antiviral agents; animal modeling of microbial infections and neuroinflammation.